LY 316108

Drug Profile

LY 316108

Alternative Names: NNC 112192

Latest Information Update: 09 Feb 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Eli Lilly; Novo Nordisk
  • Class Analgesics; Irritable bowel syndrome therapies; Small molecules
  • Mechanism of Action Muscarinic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Irritable bowel syndrome; Pain

Most Recent Events

  • 09 Feb 2000 No-Development-Reported for Irritable bowel syndrome in Denmark (PO)
  • 09 Feb 2000 No-Development-Reported for Irritable bowel syndrome in USA (PO)
  • 09 Feb 2000 No-Development-Reported for Pain in Denmark (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top